Spots Global Cancer Trial Database for unresectable malignant pleural mesothelioma
Every month we try and update this database with for unresectable malignant pleural mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM) | NCT02357147 | Mesothelioma, M... | Placebo Amatuximab Pemetrexed Cisplatin | 18 Years - | Morphotek | |
Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma | NCT02293005 | Lung Cancer Mesothelioma | Alisertib | 18 Years - | M.D. Anderson Cancer Center |